CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Regulation FD disclosure · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Grant or award Director acquired 70,822 shares (grant or award)
- 8-K/A Event Material agreement · Agreement ended · Unregistered share sale · Director nominations · Regulation FD disclosure · Other events
- 8-K Event Exhibits
- 10-Q Report Quarterly Report
- S-1/A Offering Registration Statement
- 8-K Event Other events
- S-1/A Offering Registration Statement
- 8-K Event Results of operations
- S-1 Offering Registration Statement
- 4 Grant or award Director acquired 5,384 shares (grant or award)
- 4 Grant or award Director acquired 5,384 shares (grant or award)
- 4 Grant or award Director acquired 5,384 shares (grant or award)
- 8-K Event Regulation FD disclosure
Page 4 of 28 · 547 filings